Everpure drops 7% as peers sell off and earnings loom

Everpure ends the week with a sharp single-day reversal, falling 7.4% on October 30 to $126.98, even as the stock held a modest weekly gain of 3% and peers absorbed heavier losses around it.

The peer context matters here. Closest correlated names all fell hard on the day: NTAP dropped 8.8%, DELL lost 10.8%, and HPE gave up 6.4%. Everpure's own decline looks less like a company-specific event and more like the sector selling through a rough session. On a weekly basis the stock still outperformed all three, which is consistent with its broader 2026 pattern of relative resilience in a difficult hardware tape.

Short positioning has continued to build quietly, as noted in last week's note, and the direction has not changed. Short interest is now 2.76% of free float, up 10.5% over the past week and 18.6% over the past month. That accumulation has been running steadily since late September, when the stock was added to the S&P 500 from the MidCap 400. The borrow market offers no friction to this trade: availability remains effectively unconstrained, with roughly 224 million shares available against fewer than 9.1 million shorted. Cost to borrow is 0.44%, barely moved on the week. The ORTEX short score of 31.9 sits in the lower half of the universe. This remains a measured hedge into a known event, not a crowded short or a squeeze candidate.

Options positioning has drifted more defensive over the past month, which is the more interesting shift. The put/call ratio of 0.84 is close to its 52-week high of 0.90 and has been running above 0.84 for most of October, compared to readings in the 0.75 to 0.79 range through late September. The 20-day mean is 0.83 and the z-score is just 0.33, so the absolute level is not extreme, but the directional move is clear: options buyers have progressively added more put exposure as the November 18 earnings date approaches. That is consistent with the short interest trend.

The Street remains broadly constructive. All 12 rated analysts carry buy-equivalent recommendations with a consensus mean target of $151. In early October, Guggenheim raised its target from $150 to $215 while maintaining its Buy rating, and Needham moved from $150 to $185. Both moves followed the September earnings print, which saw the stock gain 9.9% the day after results and 17.9% over the following five trading days. The prior event, reported in August, went the other way: down 3.5% on the day and down 10.1% over five days. Two data points make no pattern, but the asymmetry in outcomes is worth carrying into November 18. The bull case rests on hyperscaler contract backlog running through 2028 and 2029, with TAM estimates rising from roughly 60 exabytes in 2027 to 140 exabytes in 2029. Bears focus on the sustainability of memory price inflation, long sales cycles, and the risk that subscription ARR growth disappoints.

One ownership note worth flagging: John Colgrove, the Chief Visionary Officer and the company's largest individual holder with 3.16% of shares, sold roughly $10.6 million across multiple tranches on October 14 under a pre-arranged 10b5-1 plan. Director Scott Dietzen sold a further $8.5 million on the same date outside of a 10b5-1 plan. Planned sales by executives are a weaker signal than discretionary ones, but the Dietzen sale carries more weight given the absence of a pre-arranged plan. BlackRock also filed a Schedule 13G/A on October 27 showing its stake trimmed to 7.5% from a previous 10.1%, a reduction of around 2.6 percentage points. Vanguard Capital Management filed an amendment on October 30 moving in the opposite direction, raising its stake from 5.08% to 7.36%.

The buyback programme offers a separate data point. ORTEX Alt Data shows remaining buyback authorisation of $244.9 million as of Q2, up 62% on the same quarter last year and the largest Q2 reading on record since 2020. That authorisation provides a mechanical floor to consider against the insider selling. Retail attention has also spiked: the Wikipedia views signal is running at a z-score of 4.1 against Everpure's own 90-day history, a level that reflects elevated interest rather than any revenue signal.

With earnings on November 18, the session to watch is not this one but the one after the print: the last comparable release produced a near-10% gain, and the one before it a 3.5% loss, with the five-day windows showing even wider dispersion in both directions.